The FDA has approved Adcetris to treat adult patients with previously untreated stage III or IV classical Hodgkin lymphoma in combination with chemotherapy...
The post FDA expands approval of Adcetris for Stage III or IV classical Hodgkin lymphoma appeared first on European Pharmaceutical Review.
Original Article: FDA expands approval of Adcetris for Stage III or IV classical Hodgkin lymphoma
NEXT ARTICLE